Analysis of AHR targets also indicated lower CYP1A1 (Fig. 5b) and CYP1B1 mRNA levels (Fig. 5c) in CD14+ cells isolated from RA than from OA patients; CYP1A2 was not expressed in CD14+ cells (not shown). The gene discussed is CYP1A2; the disease is rheumatoid arthritis.